News
At its first look during the Annecy Festival, director Guillaume Dousse reeled off a list of inspirations for the Netflix ...
11d
Comic Basics on MSNNew Look at ‘Splinter Cell: Deathwatch’ Animated Series Featuring Liev Schreiber as Sam Fisher
Netflix is set to bring the popular Tom Clancy’s Splinter Cell video game to life in a new animated series called Splinter ...
11d
Fiction Horizon on MSNNew Look at ‘Splinter Cell’ Animated Series: Liev Schreiber Voices Iconic Spy
Netflix is gearing up to release a new animated series called Splinter Cell: Deathwatch, based on the popular Tom Clancy’s ...
The open benchmark competition will evaluate the ability of AI-powered virtual cell models to generalize to new cell contexts for therapeutic applications.
Health New stem cell therapy shows 'promising' results for treating hair loss in preclinical trials Androgenetic alopecia treatment led to complete hair regrowth in some mice, research shows ...
Texas Governor Greg Abbott signed a recently passed bill into law Sunday that will ban K-12 students from using cell phones and other personal communications devices during the school day.
A Texas bill which would ban K-12 students from using cell phones during school hours has been signed into law by Gov. Greg Abbott.
Zimislecel is an allogeneic stem cell–derived islet-cell therapy. Data on the safety and efficacy of zimislecel in persons with type 1 diabetes are needed.
The original Splinter Cell just got a big unofficial remaster thanks to modders Assassin's Creed Shadows' creator Ubisoft's landmark 2002 stealth game, Splinter Cell, can now be played in higher ...
CAR T-cell therapy has the potential to revolutionise how we treat certain types of cancer by genetically engineering someone’s own immune cells to attack the disease – but it is also ...
Kennedy researchers have uncovered key design parameters for bispecific T-cell engagers (TcEs)—a class of cancer immunotherapy drugs. The findings may help unlock the full potential of TcEs and ...
Following a disappointing performance from the company’s CAR-T candidate in an early-stage cancer trial, BioNTech is winding down cell therapy manufacturing at its inaugural U.S. plant.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results